A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

RP McLaughlin, JC He, VE van der Noord, J Redel, John Foekens, John Martens, Marcel Smid, YH Zhang, B van de Water

Research output: Contribution to journalArticleAcademicpeer-review

46 Citations (Scopus)
14 Downloads (Pure)
Original languageUndefined/Unknown
Article number77
JournalBreast Cancer Research
Publication statusPublished - 2019

Research programs

  • EMC MM-03-86-01

Cite this